AAPS 2012: Brookfield Engineering's CT3 Tester

Dec 18, 2012

Bob McGregor, Brookfield Engineering's Global Marketing Manager, demonstrates the Texture Analyzer, CT3 Tablet Tester at the 2012 AAPS Show in Chicago.

Pharma Manufacturing

AAPS 2012: Brookfield Engineering's CT3 Tester

FDA pulls 31 ANDAs from troubled generics maker

The challenges are mounting for Canadian generics drugmaker Apotex.

GSK opens continuous manufacturing plants

GlaxoSmithKline has opened two “state-of-the-art” facilities in…

Trump suggests executive order on drug prices, but is unclear on details

President Trump mentioned that the White House was writing an executive…

Fosun buys GSK plant, hepatitis B drug rights

YaoPharma, Fosun's Chongqing unit, will spend up to $36 million to buy…

Reckitt to pay $1.4B in opioid settlement

Reckitt Benckiser Group will pay up to $1.4 billion to settle U.S.

Merck begins hunt for new CEO

Merck and Co. is scouting for a replacement for its CEO, Kenneth Frazier.

Pharma's budding opportunity

Why the industry is forming bonds with CBD

Sun Pharma hit with Form 483 for Halol facility

Sun Pharmaceutical said it has received four observations from the U.S.

FDA pulls 31 ANDAs from troubled generics maker

The challenges are mounting for Canadian generics drugmaker Apotex.

Akorn hit with yet another FDA warning letter

The warning letter is the result of an inspection of the company’s…

Top 5 Drugs With the Biggest Growth Potential in 2019

In the coming year, several drugs that treat a range of diseases will far…

Merck to cut jobs, close plants with $1.2B restructuring plan

Merck and Co. has created a restructuring plan it says is designed to…

Torrent hit with Form 483

The FDA found that in hundreds of cases, batches at Torrent’s plant did…

The Highest — and Lowest — Ranked Places to Work in Big Pharma

How pharma companies fair on Glassdoor.

Anti-vaxxers turn to potatoes

A new and weird rumor has surfaced in the anti-vaccine movement: potatoes…